3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow glucokinase activator compound 50: new trials by email Literature Review of glucokinase activator compound 50 trials Research Report on glucokinase activator compound 50
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus glucokinase activator, Placebo - Type2 Diabetes Mellitus | Phase 1 | Completed | PegBio Co., Ltd. | 16 | 2019-08-27 | 2020-01-22 |
| A Study to Compare Two Forms of LY2608204 in Healthy People LY2608204 Reference, LY2608204 Test - Healthy Volunteers | Phase 1 | Completed | Eli Lilly and Company | 16 | 2011-03-01 | 2018-10-05 |
| A Study of LY2608204 in Patients With Type 2 Diabetes LY2608204 - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Eli Lilly and Company | 20 | 2010-11-01 | 2018-11-16 |
Diabetes Mellitus, Type 2 (2) · Hypoglycemia (1)
Eli Lilly and Company (2) · PegBio Co., Ltd. (1)
Singapore (2) · China (1) · United States (1)
HaiYan Li (1)